Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 5859 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 7261 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 12090 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 12236 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 18162 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 19744 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 20451 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 21314 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 21633 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 22003 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 22929 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 25385 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 25745 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 34166 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 35671 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 36239 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 37097 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 38386 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 40298 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 47059 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 49405 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 54303 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 58005 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 66475 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 102217 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+ | 506839 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 9876 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 13987 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 14184 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 14651 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 15831 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 16340 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 16605 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 16716 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 18612 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 23658 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 24869 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 25540 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 26191 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 26320 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 26692 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 34204 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 38399 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 38712 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 45666 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 66645 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 316532 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | 360772 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | Peak area normalized | female | Pre-diabetic | no neuropathy | |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | Peak area normalized | male | Diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | Peak area normalized | male | Diabetic | no neuropathy | |
Reversed phase POSITIVE ION MODE | SPHINGOSINE (M+H)+[-H2O] | Peak area normalized | male | Normoglycemic | Neuropathy |